Legislation aims to spur medical innovation

Bipartisan legislation to spur medical innovation and hasten the availability of such products to patients was introduced on Thursday.

Sen. Amy Klobuchar (D-Minn.), chairwoman of the Senate Commerce Competitiveness, Innovation, and Export Promotion Subcommittee, sponsored the Medical Device Regulatory Improvement Act to streamline the Food and Drug Administration’s regulation of medical devices by clarifying the agency’s least burdensome requirements. The bill would direct FDA regulators to focus only on “relevant information” during the decision-making process; consider “appropriate alternatives” to reduce the time, effort and cost of reaching regulatory decisions; and use “all reasonable mechanisms” to reduce review times when making their decisions.

Click here to read the full article